Literature DB >> 33215460

Expressions of SAA, CRP, and FERR in different severities of COVID-19.

S-L Liu1, S-Y Wang, Y-F Sun, Q-Y Jia, C-L Yang, P-J Cai, J-Y Li, L Wang, Y Chen.   

Abstract

OBJECTIVE: To explore the expression and significance of SAA, CRP and FERR in patients diagnosed with COVID-19. PATIENTS AND METHODS: A total of 225 patients diagnosed with COVID-19 who were admitted to the North Hospital of First Hospital in Changsha, China, from 9th February 2020 to 7th March 2020 were enrolled. Their general data, laboratory test results and levels of SAA, CRP and FERR were extracted from electronic medical records.
RESULTS: Age was an important risk factor for the severity of COVID-19 in the patients. Compared with the non-severe group, the severe group showed statistical significance in the levels of total protein, albumin, ALT and AST in liver function, UA in renal function, myocardial enzyme CK-MB and LDH, and immunoglobulin IgG and IgM. The levels of SAA, CRP, and FERR were significantly increased in patients with severe COVID-19. ROC curve analysis results showed that the AUC, from small to large, was as follows: SAA+CRP+FERR, CRP + FERR, SAA + CRP, SAA + FERR, SAA, FERR, and CRP, which indicated the benefit of the combination of the three indicators. The sensitivity and specificity of the combined detection of the three indicators were higher than those of the detection of any single indicator or two combined indicators. A Spearman correlation analysis of the data showed that the initial CRP/SAA, SAA/FERR, and CRP/FERR were positively correlated. The continuous results of SAA, CRP and FERR throughout the study period showed that the values of the severe group on a given day were higher than those of the non-severe group; the values of the two groups peaked on the 5th or 7th day and then decreased, and the decreasing trend of the severe group was more evident.
CONCLUSIONS: SAA, CRP and FERR are sensitive serological indicators used to evaluate the severity of COVID-19. The combined detection of serum SAA, FERR, and CRP, which are positively related to COVID-19 infection, offers guiding significance for the occurrence of COVID-19 infection and the severity of the disease. Such detection provides effective detection indicators for the progress and prognosis of COVID-19; these indicators will enable effective intervention measures to be implemented in time and the rates of severe illness and mortality to be reduced.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33215460     DOI: 10.26355/eurrev_202011_23631

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis.

Authors:  Budao Cao; Xuefen Jing; Yan Liu; Rong Wen; Cuifeng Wang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

2.  Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.

Authors:  Ahmed N Kaftan; Majid K Hussain; Abdulhussein A Algenabi; Farah H Naser; Muslim A Enaya
Journal:  Acta Inform Med       Date:  2021-03

3.  Monocyte distribution width as a novel sepsis indicator in COVID-19 patients.

Authors:  Laila Alsuwaidi; Saba Al Heialy; Nahid Shaikh; Firas Al Najjar; Rania Seliem; Aaron Han; Mahmood Hachim
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

4.  Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19.

Authors:  Dina A Abdelhakam; Fatma Mohammed Badr; Mohammed Abd El Monem Teama; Nouran M Bahig Elmihi; Marwa Adham El-Mohamdy
Journal:  Biomed Rep       Date:  2021-12-21

Review 5.  Complement activation in COVID-19 and targeted therapeutic options: A scoping review.

Authors:  Endry Hartono Taslim Lim; Rombout Benjamin Ezra van Amstel; Vieve Victoria de Boer; Lonneke Alette van Vught; Sanne de Bruin; Matthijs Christian Brouwer; Alexander Petrus Johannes Vlaar; Diederik van de Beek
Journal:  Blood Rev       Date:  2022-07-30       Impact factor: 10.626

6.  Prognostic value of serum amyloid A in COVID-19: A meta-analysis.

Authors:  Yongkai Li; He Xiaojing; Li Zhuanyun; Dandan Li; Jianzhong Yang
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

Review 7.  Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Alessandro G Fois; Arduino A Mangoni
Journal:  Adv Med Sci       Date:  2021-07-07       Impact factor: 3.287

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.